BMRN
$BMRN
BioMarin Pharmaceutical Inc.
Rare disease biotech company with gene therapy and enzyme replacement treatments.
Healthcare$55.46
+1.40 (+2.59%)
Day Range$53.45 - $55.53
Prev Close$54.06
Analyst Rating
Strong Buy
26 Buy / 6 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
BMRN: Pipeline Recovery & Valuation Upside
BioMarin ($BMRN) trades at $55.83 with a strong buy consensus and a mean analyst target near $88.9. Forward P/E and PEG point to material upside if pipeline and guidance trends improve.
Apr 6, 2026